As appropriate biomarkers for early detection of HCC remain scarce, the addition of genetic biomarkers, such as somatic mutations in Telomerase Reverse Transcriptase (TERT) gene can further improve the diagnosis. The gene discussed is TERT; the disease is hepatocellular carcinoma.